Siddhartha Sivaramakrishnan - McDermott Will & Emery


Siddhartha Sivaramakrishnan focuses his practice on the representation of APAC and EMEA investment bank underwriters, issuers and vendors in a wide range of US and international capital markets transactions. These include numerous equity and debt offerings under Rule 144A and Regulation S and SEC-registered offerings. Siddhartha also advises on M&A, de-SPAC and restructuring transactions.

Siddhartha counsels on financial institution regulatory and compliance matters, including cross border licensing and marketing requirements and insider dealing and market abuse. He also advises on corporate governance and public company reporting requirements.

Show More


  • Advised Innovative International Acquisition Corp., a NASDAQ-listed SPAC, in its definitive merger agreement with Zoomcar, the world’s largest emerging market focused car sharing platform. The implied enterprise value of the combined company is US$456 million
  • Advised a Baltic gaming operator on its restructuring of its outstanding senior secured notes and related consent solicitation
  • Advised Kotak, Citi, Nomura and Haitong on the US$ 872 million IPO on the Bombay Stock Exchange and Rule 144A/Regulation S global offering of Gland Pharma, a leading generic injectables manufacturer majority owned by global pharmaceutical major Shanghai Fosun Pharma*

Show More


  • Chambers Global, Leading Lawyer in Singapore and India: Capital Markets, 2022
  • Chambers Asia-Pacific, Leading Lawyer in Singapore: Capital Markets International, 2023
  • Chambers Asia-Pacific, Leading Lawyer in India: Capital Markets (International Firms) – Foreign Expertise based abroad in Singapore, 2023
  • India Business Law Journal, International A-List Lawyer, 2022
  • International Financial Law Review, Leading Lawyer in Singapore: Capital Markets, 2022
  • Legal 500 Asia-Pacific, Leading Lawyer in Singapore: Capital Markets, 2021


Yale University
University of Oxford

New York
England & Wales